The global market for electrophysiology (EP) technologies employed in the catheter ablation of cardiac arrhythmias was estimated at $5.9 billion in 2019. This represented a 12.4% increase over the previous year that reflected a gradual rise in EP lab installations, an increase in the number of complex ablations performed, and the rising intensity and cost of devices employed in the treatment of complex ablations. Nearly 70% of revenues remain concentrated in the U.S. and industrialized nations of Major Europe, which have the necessary resources to address this growing field, and this share will decline only slightly through the forecast period. Overall, the growing reliability and long-term success of complex ablations will drive an 11.5% annual increase in the global performance of complex ablations through 2024 which will, in turn, drive an 11.3% real annual increase in total product sales during the same period to nearly $10.1 billion.
This report provides a detailed analysis of the market, competitors, and trends and opportunities.
Johnson & Johnson Biosense Webster
Abbott/St. Jude Medical
Medtronic
Boston Scientific
GE Healthcare
Stereotaxis
Stockert GmbH
Microport Medical
CardioFocus
Acutus Medical
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
